Flowers Foods Reports Q3 2026 Earnings Decline Amid Lower Volumes and GLP-1 Impact
Flowers Foods (FLO) reported a significant downturn in its third-quarter fiscal 2026 results, characterized by a 4.7% decrease in net sales to $1.169 billion. The company saw a sharp 63.6% drop in net income to $14.4 million, driven primarily by declining sales volumes and increased expenditures in marketing and logistics. Total business volume fell by 7.0%, with the branded retail segment experiencing an 8.6% volume drop despite favorable pricing/mix adjustments. Management attributed several headwinds to shifting consumer behaviors, specifically noting that high-income consumers—a key demographic for Dave's Killer Bread—are increasingly using GLP-1 medications, which has pressured brand consumption. Consequently, the company has revised its full-year fiscal 2026 guidance downward across sales, Adjusted EBITDA, and Adjusted Diluted EPS. To mitigate these pressures, Flowers Foods is targeting $20 million in cost savings through procurement and bakery productivity improvements.
Tickers: $FLO
Topics: cost reduction goals eps miss net income decline net sales decrease volume trends